Penumbra - PEN Total Debt to Capital

PEN (Penumbra Inc) - company brandmark

Penumbra, Inc. minimizes outsourcing by maintaining precision manufacturing in-house. A stable workforce of loyal neuroengineers is being bolstered by robotics experts. This debt-to-equity chart visualizes financial leverage, where 0.14 indicates the level of this metric. The brand's high authority among surgeons confirms its status as an innovator creating unique tools for saving lives during strokes.

penumbrainc.com (PEN): All Debt to Shareholders' Equity Ratio from 07/04/2022 to 10/30/2026

Penumbra Medical (PEN) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Stock Price Penumbra|PEN - Fair Value Consensus
- issuer market value details:
Market Capitalization Penumbra|PEN - Total Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Penumbra|PEN - Accounting Value of Company|Market Capitalization to Book Value Ratio penumbrainc.com|PEN - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Penumbra, Inc.|PEN - Long-Term Liabilities to Equity|Short-Term Debt to Capital Penumbra, Inc.|PEN - Company Cumulative Debt|Debt to Book Value Penumbra|PEN - Company Long-Term Debts|Company Current Liabilities Penumbra|Quick Ratio penumbrainc.com
- net income and valuation ratios data:
PEN - Net Financial Result
Fundamental company analysis:Penumbra
Core merchandise of Penumbra Medical

To minimize fundamental risks, investors prioritize assets with low financial leverage. This ratio is calculated as total liabilities to equity, measuring the proportion of debt financing within the balance sheet structure. For Penumbra, Inc. (PEN), which invests in costly R&D for neurovascular systems, this balance is critical for maintaining technological leadership. Analyzing changes in the leverage ratio allows for an assessment of the company's resilience to market shocks.

Main competitors

DXCM (Dexcom) - Total Debt to Capital|NOVT: All Debt to Shareholders' Equity Ratio|Total Debt to Capital HAE|INSP - Debt to Capital|Debt to Equity PROCEPT BioRobotics PRCT|All Debt to Shareholders' Equity Ratio CNMD|Pulse Biosciences - Total Debt to Capital|INMD - Total Debt to Capital|Picard Medical Inc. (PMI) - Debt to Equity|Aggregate Debt to Equity SRDX (Surmodics Inc.)|SENS (Senseonics Holdings Inc) - Total Debt to Capital|Debt to Capital neuropace.com NPCE|Total Debt to Equity Ratio TCMD (Tactile Systems Technology)|Total Debt to Capital SANUWAVE Health (SNWV)|Outset - Total Debt to Equity Ratio|Aggregate Debt to Capital ELMD (SmartVest)|LENSAR, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient avitamedical.com RCEL|PROF: Total Debt to Capital|Total Debt to Equity Ratio Baird Medical|Total Debt to Equity Ratio EDAP|APYX: All Debt to Shareholders' Equity Ratio|Debt to Equity IceCure Medical Ltd (ICCM)|Total Debt to Equity Ratio pulmonx.com LUNG|Total Debt to Capital TELA (TELA Bio)|CytoSorbents Corp (CTSO) - Debt to Capital|Sensus Healthcare Corp - Total Debt to Capital|ZYXI (Zynex Corp) - Debt to Equity Ratio|ECOR: Total Debt to Capital|RBOT - Total Debt to Capital Coefficient|IINN (Inspira Technologies Oxy B.H.N. Ltd.) - Total Debt to Capital|Total Debt to Equity Ratio SeaStar Medical Holding Corporation (ICU)|Total Debt to Capital IRIX|Total Debt to Capital ibs.inc (INBS)|Debt to Equity Beyond Air XAIR|profusa.com - Debt to Equity|SSKN: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio GCTK (glucotrack.com)|NAOV: Total Debt to Capital|Debt to Capital Venus Concept Corporation (VERO)|Debt to Equity Nuwellis, Inc.|AEMD - Debt to Capital Ratio|Total Debt to Equity Ratio ASXC (Asensus Surgical, Inc.)|Total Debt to Capital Avinger Inc. (AVGR)|Total Debt to Capital BSGM (BioSig Technologies, Inc.)|Total Debt to Capital Coefficient Cutera Inc (CUTR)|KNW - Debt to Equity|Aggregate Debt to Equity NARI|Nevro (NVRO) - Debt to Equity|Total Debt to Equity Ratio ReShape Lifesciences Inc.|SILK (Silk Road Medical Inc.) - Total Debt to Capital